Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies.

Lima PA, Berg BB, Castor MGME

DOI: 10.5217/ir.2021.00160
Published: 2022 Oct
Container: Intestinal research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.5217/ir.2021.00160,
  title = {Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies.},
  author = {Lima PA and Berg BB and Castor MGME},
  year = {2022},
  journal = {Intestinal research},
  doi = {10.5217/ir.2021.00160},
  url = {https://doi.org/10.5217/ir.2021.00160}
}

RIS

TY  - JOUR
TI  - Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies.
AU  - Lima PA
AU  - Berg BB
AU  - Castor MGME
PY  - 2022
JO  - Intestinal research
DO  - 10.5217/ir.2021.00160
UR  - https://doi.org/10.5217/ir.2021.00160
ER  -

APA

PA, L., BB, B., & MGME, C. (2022). Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies.. Intestinal research. https://doi.org/10.5217/ir.2021.00160

Source records

pubmed · retrieved 2026-11-10T13:48:05.222Z